오상헬스케어

036220KOSDAQ의료용 기기 제조업

53.3 / 100

Reference Date: 2026-06-10

Financial Score18.0 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure12.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Plunged 25.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Osang Healthcare is a company specializing in in vitro diagnostics (IVD), developing and selling biochemical, immunoassay, and molecular diagnostic products, including blood glucose meters, HbA1c devices, and cholesterol meters. It operates subsidiaries in the US and Brazil to expand its global market and is also pursuing new ventures in bio-healthcare.

Number of Employees

336people

Average Salary

57.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

28.01Industry Average 21.513.0Point

Higher than industry avg (caution)

PBR

0.32Industry Average 1.387.0Point

Half of industry avg (excellent)

ROE

1.10Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

10.95Industry Average 11.654.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼8.8% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼3.8% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 14.8% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Positive
오상헬스케어, 차세대 당뇨진단 복합기 출시 채비
오상헬스케어의 차세대 당뇨진단 복합기 출시 준비로 인해 당화혈색소 측정 분야에서의 시장 지배력 강화 기대.
Positive
오상헬스케어, 차세대 당뇨진단 복합기 'CLOVER DX D1' 출시 ...
오상헬스케어의 신규 당뇨진단 복합기 'CLOVER DX D1' 출시로 당화혈색소 측정 분야에서의 혁신적 성장 기대.
Positive
오상헬스케어, 멕시코 정부에 당화혈색소 측정기 대규모 공급…경쟁력...
오상헬스케어의 멕시코 정부에 대한 대규모 당화혈색소 측정기 공급 계약은 회사의 글로벌 경쟁력 강화와 수익 증대를 시사합니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 6,330Won52-week high 23,05052-week low 6,330

1-month return0.0Point

1m -25.18% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

5 totalPositive 1Neutral 4Negative 0

Neutral분기보고서 (2026.03)2026-05-15
Positive단일판매ㆍ공급계약체결(자율공시)2026-05-13
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-12
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-12
Neutral자기주식처분결과보고서2026-05-12